Harvard Bioscience has acquired Data Sciences International

Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, has acquired 100% of the outstanding stock of Data Sciences International, Inc. (“DSI”)...

AHN biotechnologie has been sold to Capp

Harvard Bioscience, Inc. (Nasdaq: HBIO) has sold its subsidiary, AHN Biotechnologie GmbH, to Capp ApS. Based in Nordhausen, Germany, AHN Biotechnologie specializes in the development, manufacturing and distribution of liquid handling products for the use in...

Harvard Bioscience acquires all operations of HEKA Electronik

Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of equipment, instruments and solutions to advance life science, has acquired all of the operations of HEKA Elektronik, or HEKA, a privately held biomedical...

Harvard Bioscience acquires Multi Channel Systems

Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, has acquired Multi Channel Systems MCS GmbH, a privately held life science company headquartered in Reutlingen, Germany. MCS’...

Harvard Bioscience acquires AHN Biotechnologie

Harvard Bioscience, Inc. (Nasdaq: HBIO), Holliston, MA, a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, has acquired AHN Biotechnologie GmbH (“AHN”). Based in Nordhausen, Germany, AHN...